ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Informing payers and patients of biological therapy advantages can strengthen biosimilars market
September 23, 2020Patients are unaware of the cost savings and payers are unclear if they can replace the reference biologics with the biosimilar drugs, says a GlobalData report. -
FDA chief Gottlieb blames drugmakers for ‘anemic’ biosimilar market
July 23, 2018The FDA has so far approved 11 biosimilars, drugs that should be saving patients billions of dollars. But so far, only three of the 11 have made it to the market in the U.S., a fact FDA Commissioner Scott Gottlieb, M.D., is blaming on the reference drugma -
Indian biosimilar market likely to touch $1 billion in three years
February 20, 2017According to industry estimates, India's biosimilars market could exceed $1 billion by 2020, as reported Business Standard Sunday.
Pharma Sources Insight January 2025
